Director/PDMR Shareholding

RNS Number : 4453Z

GlaxoSmithKline PLC

13 January 2011

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 January 2011 of an increase in their notional interests in Ordinary shares at a price of £12.50 per share and Ordinary Share ADRs at a price of $39.05 per ADR following the notional re-investment of the dividend paid to shareholders on 6 January 2011.

	Ordinary shares	ADRs
Mr A P Witty	16,008.43
Mr J S Heslop	6,502.83
Dr M M Slaoui		3,707.99
Mr S M Bicknell	1,019.85
Mr J M Clarke	3,799.12
Mrs D P Connelly		1,902.65
Mr M Dunoyer	1,703.78
Mr E J Gray	2,656.67
Mr S A Hussain	3,298.27
Mr W C Louv		1,199.13
Mr D J Phelan		1,891.30
Dr D Pulman		1,692.28
Mr D S Redfern	1,248.34
Mr J R Stéphenne	1,985.57
Ms C Thomas	1,714.32
Mr D E Troy		2,545.95
Dr P J T Vallance	1,517.87
Mrs V A Whyte	112.55

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

V A Whyte

Company Secretary

13 January 2011

 

END

 

 

RDSEXLFFFFFLBBB